华大基因：关于全资子公司拟与关联方联合申报科技项目暨关联交易的公告

Core Viewpoint - BGI Genomics announced the approval of a proposal for its wholly-owned subsidiary to jointly apply for a technology project with related parties, involving a related transaction [1] Group 1 - The fourth meeting of the fourth board of directors and the seventh meeting of the fourth supervisory board were held on October 23, 2025 [1] - The proposal was approved with the related director Wang Jian abstaining from the vote [1]